adenoviral vector (MUSC)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadenoviral vector (MUSC)

Drug Alias Nameprostate cancer gene therapies (MUSC)prostate cancer gene therapies (Medical University of South Carolina)oncolytic adenovirus therapy with prostate-specific promoters (MUSC)

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMedical University Of South Carolina

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedical University Of South Carolina

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A